ProQR Therapeutics N.V.ProQR Therapeutics N.V.ProQR Therapeutics N.V.

ProQR Therapeutics N.V.

No trades
See on Supercharts

Price target

6.490.000.00%
The 6 analysts offering 1 year price forecasts for PRQR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to PRQR in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


PRQR EPS for the last quarter is −0.11 USD despite the estimation of −0.12 USD. In the next quarter EPS is expected to reach −0.08 USD. Track more of ProQR Therapeutics N.V. financials and stay on top of what is up with the company.
In the next quarter ProQR Therapeutics N.V. revenue is expected to reach ‪5.38 M‬ USD. Check out ProQR Therapeutics N.V. revenue and earnings and make informed decisions.
According to analysts, PRQR price target is 6.49 USD with a max estimate of 13.65 USD and a min estimate of 2.03 USD. Check if this forecast comes true in a year, meanwhile watch ProQR Therapeutics N.V. stock price chart and keep track of the current situation with PRQR news and stock market news.
We've gathered opinions of 6 analysts rating PRQR stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.